Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

Tina T. Biss, Peter J. Avery, Leonardo R. Brandão, Elizabeth A. Chalmers, Michael D. Williams, John D. Grainger, Julian B. S. Leathart, John P. Hanley, Ann K. Daly, Farhad Kamali

Blood (2012) 119 (3): 868–873.

https://doi.org/10.1182/blood-2011-08-372722

Published: 2012

Journal Articles

A novel thromboxane A 2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

Andrew D. Mumford, Ban B. Dawood, Martina E. Daly, Sherina L. Murden, Michael D. Williams, Majd B. Protty, Jennifer C. Spalton, Mark Wheatley, Stuart J. Mundell, Steve P. Watson

Blood (2010) 115 (2): 363–369.

https://doi.org/10.1182/blood-2009-08-236976

Published: 2010

Journal Articles

Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis

Bryan Lo, Ling Li, Paul Gissen, Hilary Christensen, Patrick J. McKiernan, Charles Ye, Mohamed Abdelhaleem, Jason A. Hayes, Michael D. Williams, David Chitayat, Walter H. A. Kahr

Blood (2005) 106 (13): 4159–4166.

https://doi.org/10.1182/blood-2005-04-1356

Published: 2005

Journal Articles

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

M. Said Enayat, Andrea M. Guilliatt, Gurcharan K. Surdhar, P. Vincent Jenkins, K. John Pasi, Cheng Hock Toh, Michael D. Williams, Frank G. H. Hill

Blood (2001) 98 (3): 674–680.

https://doi.org/10.1182/blood.V98.3.674

Published: 2001

Journal Articles

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Gurcharan K. Surdhar, Mohammad S. Enayat, Sarah Lawson, Michael D. Williams, Frank G. H. Hill

Blood (2001) 98 (1): 248–250.

https://doi.org/10.1182/blood.V98.1.248

Published: 2001

NARROW

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

A novel thromboxane A 2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Email alerts

ASH Publications

American Society of Hematology

VKORC1 and CYP2C9 genotype and patient characteristics explain a large proportion of the variability in warfarin dose requirement among children

A novel thromboxane A 2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis

Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet α-granule biogenesis

Aberrant dimerization of von Willebrand factor as the result of mutations in the carboxy-terminal region: identification of 3 mutations in members of 3 different families with type 2A (phenotype IID) von Willebrand disease

Homozygous gene conversion in von Willebrand factor gene as a cause of type 3 von Willebrand disease and predisposition to inhibitor development

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only